Patients struggle to get weight loss drug ahead of price rise
The article discusses the struggles patients are facing in obtaining a weight loss drug in the UK ahead of a planned price increase. The drug's manufacturer, based in the US, has instructed UK distributors to stop accepting orders from pharmacies until the price increase takes effect next month. This move has led to concerns among patients who rely on the drug for their weight management. The article highlights the difficulties they are experiencing in accessing the medication, which could have significant implications for their health and well-being. The article does not provide specific details about the reasons behind the price increase or the extent of the impact on patients. However, it emphasizes the challenges faced by individuals seeking to obtain this weight loss drug, as they navigate the changes in the supply chain and potential price changes.
Source: For the complete article, please visit the original source link below.
